Published works

Urinary liver-type fatty acid binding protein as a postoperative marker of acute kidney injury in patients undergoing endovascular aortic aneurysm repair.

Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.

Evaluation of Serum L-FABP as a Biomarker and Hepatoprotective Effect of L-FABP Using Wild-Type and Human L-FABP Chromosome Transgenic Mice.

Combination of Urinary Biomarkers for Early Detection of Patients With Acute Kidney Injury After Transcatheter Aortic Valve Implantation.

Interstitial Nephritis Induced by Repeated Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Use for Persistent Fever: A Case Report.

Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration predictions.

Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.

Urinary L-FABP: A Novel Biomarker for Evaluating Diabetic Nephropathy Onset and Progression. A Narrative Review.

Combination of urinary biomarkers can predict cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.

Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.

Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy.

Liver fatty acid-binding protein point-of-care testing detects heat-induced organ damage: a pilot study in Japanese male self-defense force personnel.

The feasibility of point-of-care testing for initial urinary liver fatty acid-binding protein to estimate severity in severe heatstroke.

Prognostic values of proteinuria in patients with acute heart failure.

The Urinary Liver-Type Fatty Acid Binding Protein (L-FABP) in Early Detection and Outcome Prediction of Sepsis-Associated Acute Kidney Injury.

Estimated Proximal Tubule Fluid Phosphate Concentration and Renal Tubular Damage Biomarkers in Early Stages of Chronic Kidney Disease.

Clustering based on renal and inflammatory admission parameters in critically ill patients admitted to the ICU.

Topiroxostat-A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review.

Diagnostic Accuracy of L-FABP-to-Creatinine Ratio (LCR) for Prediction of Kidney Damage in Type-2 DM Patients Taking Albumin-to-Creatinine Ratio (ACR) as Gold Standard.

ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.